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Biomedical applicationNanocellulose, a unique and promising natural material extracted from native cellulose,
has gained much attention for its use as biomedical material, because of its remarkable
physical properties, special surface chemistry and excellent biological properties (biocom-
patibility, biodegradability and low toxicity). Three different types of nanocellulose, viz.
cellulose nanocrystals (CNC), cellulose nanoﬁbrils (CNF) and bacterial cellulose (BC), are
introduced and compared in terms of production, properties and biomedical applications
in this article. The advancement of nanocellulose-based biomedical materials is summa-
rized and discussed on the analysis of latest studies (especially reports from the past ﬁve
years). Selected studies with signiﬁcant ﬁndings are emphasized, and focused topics for
nanocellulose in biomedicine research in this article include the discussion at the level
of molecule (e.g. tissue bioscaffolds for cellular culture; drug excipient and drug delivery;
and immobilization and recognition of enzyme/protein) as well as at the level of macro-
scopic biomaterials (e.g. blood vessel and soft tissue substitutes; skin and bone tissue
repair materials; and antimicrobial materials). Functional modiﬁcation of nanocellulose
will determine the potential biomedical application for nanocellulose, which is also intro-
duced as a separated section in the article. Finally, future perspectives and possible
research points are proposed in Section 5.
 2014 Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Contents1. What is nanocellulose? – Types and productions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 303
2. Why the choice of nanocellulose? – Unique properties in physics, chemistry and biology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3042.1. Mechanical properties and potential nanoreinforcement . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 304
2.2. Surface chemistry . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 305
2.3. Biological properties . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3062.3.1. Biocompatibility and hemocompatibility . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 306
2.3.2. Biodegradability in vivo . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 306
2.3.3. Toxicology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 307
3. Nanocellulose-based biomedical materials. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 308
3.1. Tissue bioscaffolds for cellular culture. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 308
3.2. Drug excipient and drug delivery. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 311
N. Lin, A. Dufresne / European Polymer Journal 59 (2014) 302–325 3033.3. Immobilization and recognition of enzyme/protein . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 312
3.4. Substitutes/medical biomaterials . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3143.4.1. Blood vessel replacement. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 314
3.4.2. Soft tissue–ligament, meniscus, and cartilage replacements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 315
3.4.3. Nucleus pulposus replacement . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3163.5. Advanced nanomaterials for tissue repair, regeneration and healing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 316
3.5.1. Skin tissue repair and wound healing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 316
3.5.2. Bone tissue regeneration and healing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 317
3.5.3. Other tissue repair . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3173.6. Antimicrobial nanomaterials . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 317
3.7. Other biomedical applications . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3184. Functional modification of nanocellulose for potential biomedical application. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 319
5. Conclusions and remarks . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 320
Acknowledgement . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 320
Appendix A. Supplementary material. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 320
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3201. What is nanocellulose? – Types and productions
With the emergence and development of nanotechnol-
ogy, cellulose, the most ancient and important natural
polymer on earth revives and attracts more attention in
the new form of ‘‘nanocellulose’’ to be used as novel and
advanced material. Nanocellulose is described as the prod-
ucts or extracts from native cellulose (found in plants, ani-
mals, and bacteria) composed of the nanoscaled structure
material. Generally, the family of nanocellulose can be
divided in three types, (1) cellulose nanocrystals (CNC),
with other designations such as nanocrystalline cellulose,
cellulose (nano) whiskers, rod-like cellulose microcrystals;
(2) cellulose nanoﬁbrils (CNF), with the synonyms of nano-
ﬁbrillated cellulose (NFC), microﬁbrillated cellulose (MFC),
cellulose nanoﬁbers; and (3) bacterial cellulose (BC), also
referred to as microbial cellulose [1,2].
The sources for CNC and CNF extraction are wood, cot-
ton, hemp, ﬂax, wheat straw, sugar beet, potato tuber, mul-
berry bark, ramie, algae, and tunicin. As shown in Fig. 1
(top images), the production of CNC or CNF is a procedure
consisting in converting the large unit (cm) to the small
unit (nm). Chemically induced destructuring strategy, such
as acid hydrolysis, is commonly performed for the extrac-
tion of CNC from native cellulose, through the removal of
amorphous regions and preservation of highly-crystalline
structure. Released nanoparticles (CNC) present a diameter
of 5–30 nm, and length of 100–500 nm (from plant cellu-
lose), or length of 100 nm to several micrometers (from
tunicate and algae celluloses). With microscopic observa-
tions and light scattering techniques, the morphology
and dimensions of CNC can be assessed as elongated rod-
like (or needle-like) nanoparticles, and each rod can there-
fore be considered as a rigid cellulosic crystal with no
apparent defect [3].
Regarding the preparation of CNF, mechanically induced
destructuring strategy is mainly applied, which involves
high-pressure homogenization and/or grinding before and/
or after chemical or enzymatic treatment.Multiplemechan-
ical shearing actions can effectively delaminate individual
microﬁbrils from cellulosic ﬁbers. Different from rigid
CNC, CNF consists of both individual and aggregated nanoﬁ-brils made of alternating crystalline and amorphous cellu-
lose domains, which attributes the morphology of CNF
with soft and long chains. Due to the entanglement of long
cellulosic chains, it is not so easy to determine the length
of CNF (commonly regarded as higher than 1 lm) with
microscopic techniques. Therefore, only the information of
ﬁbril width for CNF is generally provided in the studies,
which varies from 10 to 100 nm depending on the source
of cellulose, deﬁbrillation process and pretreatment [4].
Contrary to the production of CNC and CNF, the biosyn-
thesis of BC is a process of construction from tiny unit (Å)
to small unit (nm). As shown in Fig. 1 (bottom images), BC
is typically synthesized by bacteria (such as Acetobacter
xylinum) in a pure form which requires no intensive pro-
cessing to remove unwanted impurities or contaminants
such as lignin, pectin and hemicellulose. During the bio-
synthesis of BC, the glucose chains are produced inside
the bacterial body and extruded out through tiny pores
present on the cell envelope. With the combination of glu-
cose chains, microﬁbrils are formed and further aggregate
as ribbons (nanoﬁbers) [11]. These ribbons subsequently
generate a web-shaped network structure with cellulosic
ﬁbers (BC), which has a diameter of 20–100 nm with dif-
ferent types of nanoﬁber networks.
It is crucial to discuss the issue of large-scale production
of nanocellulose, which determines the practical applica-
tions of nanocellulose as available commercial products.
According to the reports of ‘‘Future Markets Inc.’’ [12], a
number of organizations have announced CNF and CNC
demonstration plants in Europe and North America. It
seems that the countries in North America focus on the
production of CNC, such as reported organizations of Bio
Vision (Canada), CelluForce (Canada) and US Forest Service
Forest Products Laboratory (USA); while European coun-
tries are more interested in CNF, for instance reported
organizations of Centre Technique du Papier (France), Stora
Enso (Finland), UPM Fibril cellulose (Finland), Borregaard
Chemcell (Noway), etc. In comparison with the large-scale
production of CNC and CNF, the production of BC is rather
limited, resulting from high cost to support the growth of
bacteria and low yield. Despite numerous bioreactors that
have been studied in the literature to produce BC on large
Fig. 1. Hierarchical structure of cellulose; top image (from large unit to small unit): cellulose nanocrystals (CNC), micro/nanoﬁbrillated cellulose (MFC and
NFC); bottom image (from tiny unit to small unit): bacterial cellulose (BC). Transmission electron micrographs of sugar beet MFC (adapted with permission
from [5]), hardwood MFC (adapted with permission from [6]), ramie CNC (adapted with permission from [7]); and scanning electron micrographs of BC
ribbons (adapted with permission from [8]), nata-de-coco BC (adapted with permission from [9]), BC pellicle (adapted with permission from [10]).
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the aerosol bioreactor [13]. The organization of Jenpoly-
mers (Germany) and Nutrasweet Kelco Company (USA,
with the trade name of Primacel in the 1990s) were ever
reported to produce BC and related biomedical products.2. Why the choice of nanocellulose? – Unique properties
in physics, chemistry and biology
As natural nanoscaled material, nanocellulose possesses
diverse characteristics different from traditional materials,
including special morphology and geometrical dimensions,
crystallinity, high speciﬁc surface area, rheological proper-
ties, liquid crystalline behavior, alignment and orientation,
mechanical reinforcement, barrier properties, surface
chemical reactivity, biocompatibility, biodegradability,
lack of toxicity, etc. On the basis of these unique properties,both ‘‘nano-enhanced’’ and completely new ‘‘nano-
enabled’’ products have been envisioned ranging from bulk
applications like rheological modiﬁer, composite reinforce-
ment or paper additive, to high-end applications such as
tissue engineering, drug delivery and functional material
[14]. All the properties of nanocellulose can be generally
classiﬁed in three parts, viz. physical properties, surface
chemistry, and biological properties. Associated with the
topic ‘‘biomedicine’’, the emphasis of this article is mainly
placed on the mechanical reinforcement, surface groups
and charges, as well as various biological properties of
nanocellulose.2.1. Mechanical properties and potential nanoreinforcement
The mechanical properties of nanocellulose can be char-
acterized by its properties in both the ordered (crystalline)
Fig. 2. Schematic representation of the chemical structure and intra-, inter-molecular hydrogen bonds in crystalline cellulose.
1 For interpretation of color in Fig. 2, the reader is referred to the web
version of this article.
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Cellulosic chains in disordered regions contribute to the
ﬂexibility and plasticity of the bulk material, while those
in ordered regions contribute to the stiffness and elasticity
of the material. The modulus of different types of nanocel-
lulose is expected to result from a mixing rule between the
modulus of the crystalline domains and the amorphous
fraction. Therefore, the stiffness and modulus of CNC with
more crystalline regions should be higher than those of
CNF and BC ﬁbrils with both crystalline and amorphous
structures.
Since 1930s, the elastic modulus of crystalline cellulose
has been investigated either by theoretical evaluations or
by experimental measurements (wave propagation, X-ray
diffraction, Raman spectroscopy, and atomic force micros-
copy). A broad range of values was reported, and it is gen-
erally accepted that the Young’s modulus of crystalline
cellulose (assimilated to the one of CNC) should be in the
range 100–200 GPa, which gives speciﬁc values similar to
Kevlar (60–125 GPa) and potentially stronger than steel
(200–220 GPa). Recently, the elastic modulus of crystalline
cellulose was investigated from atomistic simulations
using both the standard uniform deformation approach
and a complementary approach based on nanoscale inden-
tation, which was reported as 139.5 ± 3.5 GPa (similar to
Kevlar) [15]. In another study, Dri et al. performed the
atomic structure model of cellulose in tandem with quan-
tummechanics to compute the Young’s modulus of crystal-
line cellulose, which predicted the modulus of crystalline
cellulose as high as 206 GPa (similar to steel) [16].
Again, a broad range of values for the longitudinal mod-
ulus of cellulose microﬁbrils (involving both CNF and BC)
was reported based on different theoretical and experi-
mental strategies. The accepted average value is around
100 GPa for the modulus of cellulose microﬁbril. A three-
point bending experiment using atomic force microscopy
tips was performed on cellulose microﬁbrils to calculate
the elastic modulus. The dimension of cellulose microﬁ-
brils was found to signiﬁcantly affect the mechanical prop-
erties, and a value of 81 ± 12 GPa was reported to be the
longitudinal modulus of pulp CNF [17]. Recently, the mod-
ulus of BC was reported as 114 GPa through the analysis ofa Raman spectroscopic technique, which involved the
determination of local molecular deformation of BC via a
shift in the central position of the 1095 cm–1 Raman band
[18].
Originated from these impressive mechanical proper-
ties, nanocellulose has been potentially used as a load-
bearing element for various host materials. With the
homogenous dispersion and strong interfacial adhesion,
the presence of high-modulus nanocellulose can exhibit
the promising nanoreinforcement allowing proper stress
transfer from host material (matrix) to the reinforcing
phase (nanocellulose).
2.2. Surface chemistry
From a structural point of view, cellulose is a high
molecular weight homopolysaccharide composed of b-
1,4-anhydro-D-glucopyranose units (Fig. 2). These units
do not lie exactly in the plane with the structure, but rather
they assume a chair conformation with successive glucose
residues rotated through an angle of 180 about the molec-
ular axis and hydroxyl groups in an equatorial position
[19]. The ability of these hydroxyl groups to form hydrogen
bonds plays a major role in the formation of ﬁbrillar and
semicrystalline packing, which governs the important
physical properties of this highly cohesive material [20].
As indicated with blue dashed lines in Fig. 2, intramolecu-
lar hydrogen bonds occur primarily between the hydrogen
borne by the OH group of the C3 carbon and ring oxygen of
the adjacent glucose unit (O5). The intermolecular hydro-
gen bonds occur between the hydrogen of the OH–6 pri-
mary hydroxyl and oxygen in position O3 in a cycle of a
neighboring unit, as well as the hydrogen of OH–2 and
oxygen in position O6.
It is well known that the unidirectional parallel orienta-
tion of cellulose chains within the elementary ﬁbrils,
occurring during biosynthesis and deposition, induces the
formation of crystals having hydroxyl functionality on
one end, known as the non-reducing end (shown in pink1
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as the reducing end (shown in green in Fig. 2).
One of the most speciﬁc characteristics of cellulose is
that each of its glucose unit bears three hydroxyl groups,
which endows nanocellulose a reactive surface covered
with numerous active hydroxyl groups. For each anhydro-
glucose unit, the reactivity of hydroxyl groups on different
positions is heterogeneous. The hydroxyl group at the 6
position acts as a primary alcohol whereas the hydroxyl
groups in the 2 and 3 positions behave as secondary alco-
hols. Indeed, the carbon atom which carries the hydroxyl
group in the 6 position is only attached to one alkyl group,
while the carbons with the hydroxyl groups in the 2 and 3
positions are joined directly to two alkyl groups, which will
induce steric effects derived from the supramolecular
structure of cellulose and the reacting agent [21]. It has
been reported that on the structure of cellulose, the hydro-
xyl group at the 6 position can react ten times faster than
the other OH groups, while the reactivity of the hydroxyl
group on the 2 position was found to be twice that of at
the 3 position [22]. However, regarding the surface reactiv-
ity of hydroxyl groups from nanocellulose (such as CNC),
the use of reactants or solvents may affect the reactivity
of hydroxyl groups from different positions. Recent studies
reported the order of reactivity for hydroxyl groups on CNC
as nucleophiles with OH-C6 = OH-C2 > OH-C3 by etheriﬁ-
cation [23,24].
Apart from reactive groups, another important issue for
the surface chemistry of nanocellulose is the surface
charges, which mainly refers to the negative sulfate esters
ð—OSO3 Þ on CNC. Surface sulfate esters are introduced on
CNC during sulfuric acid hydrolysis via condensation ester-
iﬁcation (sulfation) between surface hydroxyls and a
H2SO4 molecule, using another H2SO4 molecule as a con-
densation agent. The H2SO4 hydrolyzed CNC, therefore,
are highly negatively charged, and form a well-dispersed
aqueous colloidal suspension. Surface charge amount from
sulfate groups on CNC can be controlled through the dura-
tion and temperature of H2SO4 hydrolysis. Besides the
promotion of high stability of CNC in solvents, surface
—OSO3 groups with negative charges also provide CNC
the accessibility for biomedical application, such as elec-
trostatic adsorption of enzymes or proteins [25].
2.3. Biological properties
2.3.1. Biocompatibility and hemocompatibility
Biocompatibility is referred to as the ability of a foreign
material implanted in the body to exist in harmony with
tissue without causing deleterious changes, which is an
essential requirement for biomedical materials [26].
Regarding the evaluation of cellulose biocompatibility, dif-
ferent studies provide various results due to the range of
methodologies and sample preparations. According to the
early reports [27,28], cellulose can be generally considered
to be broadly biocompatible, invoking only moderate (if
any) foreign body responses in vivo. However, it is well
known that cellulose is not readily degraded by the human
body because it lacks cellulolytic enzymes, which will
inevitably cause some incompatibility. It is a pity that
direct investigations on the biocompatibility of CNC andCNF are rare. Some studies on CNC-based materials (such
as hydrogels) only report experiments of cell cultivation,
through the growth, propagation and activity of cells to
evaluate the conditions of material biocompatibility.
Diverse CNC-based materials as bioscaffolds for cell culti-
vation will be further discussed in following section.
Hemocompatibility (or blood compatibility) is another
signiﬁcant property of biocompatibility, especially for
blood-contacting biomaterials and artiﬁcial organs, such
as artiﬁcial blood vessels, pumps, and artiﬁcial hearts.
Interestingly, recent study reported the regulation of blood
metabolic variables by the presence of TEMPO-oxidized
cellulose nanoﬁbers. The oral administration of TEMPO-
oxidized cellulose nanoﬁbers to mice was proved to be
effective for reducing the postprandial blood glucose,
plasma insulin, glucose-dependent insulinotropic polypep-
tide, and triglyceride concentrations. It seems that TEMPO-
oxidized cellulose nanoﬁbers have both promising
hemocompatibility and unique biological activities [29].
Attributed to its biosynthesis procedure, BC is com-
monly regarded as a material possessing better biocompat-
ibility than other types of nanocellulose. With an in vivo
study of subcutaneous BC implantation in rats for
12 weeks [30], no ﬁbrotic capsule or giant cells were found,
indicating no foreign body reaction for the introduction of
BC in animals. Meanwhile, ﬁbroblasts inﬁltrated BC, which
was well integrated into the host tissue, did not elicit any
chronic inﬂammatory reactions [30]. Gama et al. investi-
gated the biocompatibility of small-diameter BC and
peptide (Arg-Gly-Asp)-modiﬁed BC membranes subcuta-
neously implanted in sheep for 1–32 weeks. Compared
with negative control samples [expanded polytetraﬂuoro-
ethylene (ePTFE)], peptide-modiﬁed BC membranes were
only mildly irritating to the tissue, with no signiﬁcant dif-
ferences in the inﬂammation degree [31]. In another study,
in vivo biocompatibility of the BC membrane was analyzed
through histological analysis of long-term subcutaneous
implants in mice. BC implants caused a mild and benign
inﬂammatory reaction that decreased with time and did
not elicit a foreign body reaction. Moreover, no differences
were observed between the controls and implanted ani-
mals in thymocyte populations and in B lymphocyte pre-
cursors and myeloid cells in the bone marrow [32]. With
the plasma recalciﬁcation time and whole blood clotting
experiments, Gama et al. studied the hemocompatibility
of BC and BC-based biomaterials. It was reported that
native BC and peptide (Arg-Gly-Asp)-modiﬁed BC mem-
branes both preserved original conformational structures
and exhibited a favorable interaction (non-activation) with
platelets, which indicated BC andmodiﬁed BC as promising
hemocompatible biomaterials [33]. Similar conclusions
were recently reported for the hemocompatibility study
of BC/polypyrrole [34] and BC/polyvinyl alcohol biocom-
posites [35].
2.3.2. Biodegradability in vivo
For some applications (e.g. artiﬁcial heart valves or
menisci), biocompatible, non-biodegradable materials
may be acceptable whereas for other applications (e.g. arti-
ﬁcial bone grafts), the bioresorbable material enabling tis-
sue regeneration is preferable [36]. In terms of
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biodegradable in vivo or, at best, slowly degradable, due
to the lack of cellulase enzymes in animals. However, the
form (i.e. crystallinity, hydration and swelling) of cellulose
may affect the degree of degradation, absorption and
immune response. Nonenzymatic, spontaneous biodegrad-
ability of cellulose chains may perhaps account for slow
breakdown of unaltered cellulose within the human body,
though this is admittedly conjecture and has not been ade-
quately studied [37]. In an early in vivo study, Miyamoto
et al. found that the degradation of cellulose and cellulose
derivatives in canine specimens depended signiﬁcantly on
the cellulose crystalline form and chemical derivatization
[27]. Regenerated cellulose prepared by deacetylation of
cellulose acetate (presumably the highly crystalline cellu-
lose II polymorph) did not measurably degrade over the
course of the 6-week experiment. Contrarily, however, up
to 75% (w/w) of equivalent samples of amorphous regener-
ated cellulose were degraded and absorbed over the same
experimental period. Another study reported that CNC was
actually more biodegradable than fullerenes and carbon
nanotubes in aqueous environments, but without the
in vivo investigation of biodegradability [38]. Recently, oxi-
dized cellulose was rendered more vulnerable to hydroly-
sis and therefore potentially degradable by the human
body. Based on this strategy, researchers attempted to
enhance the biodegradability of nanocellulose through oxi-
dation, such as the report of improving BC degradability
in vitro (in water, phosphate buffered saline, and simulated
body ﬂuid) through periodate oxidation [39,40]. With the
pre-c-irradiation and sodium periodate oxidation treat-
ments on BC membranes, it was reported that in vitro deg-
radation of oxidized BC involved two major phases, (1)
initial rapid degradation of about 70–80% of the entire
sample; (2) slower degradation of an additional 5–10%
which eventually levels off leaving a small amount of non-
resorbable material. Further experiments on in vivo degra-
dation (male New Zealand White rabbits) showed the
marked degradation of oxidized BC membranes at all-time
points, with the most rapid degradation occurring in the
ﬁrst 2–4 weeks [41].
2.3.3. Toxicology
Even though earlier studies have reported nanocellu-
lose to have no or low toxicity (comparable to that of table
salt), when used as biomedical materials, the issues of tox-
icology and safety concerns for these natural nanomateri-
als should be further emphasized. Since the beginning
over twenty years ago, the nanotoxicology research for
nanoparticles has built a comprehensive assessment
system, such as for metallic nanoparticles (Au, Ag nanopar-
ticles, quantum dot, etc.) and carbon nanotubes. However,
the toxicology study of nanocellulose and nanocellulose-
based biocomposites is still restricted at a very preliminary
stage (mainly on the level of cytotoxicity). Table 1 summa-
rizes recent reports on toxicology experiments and conclu-
sions for nanocellulose. On the whole, there is no evidence
for serious inﬂuence or damage of nanocellulose on both
cellular and genetic level as well as in vivo organ and ani-
mal experiments. However, the inhalation of plentiful
nanocellulose (especially for CNC) may induce pulmonaryinﬂammation due to the easy self-aggregation and non-
degradation of nanocellulose in the body of animals.
Kovacs et al. initially studied the inherent eco-toxicol-
ogy of cellulose nanocrystals with aquatic organisms
(different species of ﬁsh) [42]. Rainbow trout hepatocytes
were selected as the model cells, and the toxicity monitor-
ing program as well as the in-depth toxicity assessment
component was included in the toxicity testing strategy.
With the eco-toxicological characterization, CNC was
found to have low toxicity potential and environmental
risk, but showed no harm to aquatic organisms at concen-
trations that could occur in receiving waters. In another
report, the cytotoxicity of CNC against nine different cell
lines was determined both by 3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazoliumbromide (MTT) assay and lac-
tate dehydrogenase (LDH) assay, and no cytotoxic effects
of CNC against any of these cell lines in the concentration
range and exposure time studied (0–50 lg/mL and 48 h)
were reported [46]. However, recently it was reported that
CNC may induce some slight dose-dependent cytotoxic
and inﬂammatory effects on human lung cells, especially
the risk with inhalatory exposure under high concentra-
tions of released CNC powders [43].
Regarding the toxicity of cellulose nanoﬁbrils, no
inﬂammatory effects or cytotoxicity on mouse and human
macrophages, and only low acute environmental toxicity
(assessed with kinetic luminescent bacteria test) have
been reported [47]. VTT Technical Research Centre in
Finland proposed an evaluation report on the systemic
study of CNF for in vitro cytotoxicity, genotoxicity, immu-
notoxicity, and neurotoxicity, together with pharyngeal
aspiration study on mice. The results revealed low cytotox-
icity and no DNA or chromosome damage from CNF, but
pulmonary inﬂammation for mouse experiment possibly
induced by the particulate/bacteria from CNF [49,50]. Pere-
ira et al. evaluated the in vitro cytotoxicity and the effect on
gene expression of CNF to ﬁbroblasts cells. It was reported
that low concentrations of CNF (100 lg/mL) have no obvi-
ous toxicity, whereas high concentrations of CNF (2000
and 5000 lg/mL) will cause the sharp decrease of cell via-
bility and affect the expression of stress- and apoptosis-
associated molecular markers [52]. Alexandrescu et al.
compared the cytotoxicity on ﬁbroblast cells of pure CNF
and surface modiﬁed-CNF with crosslinking agent polyeth-
yleneimine (PEI) and surfactant cetyl trimethylammonium
bromide (CTAB). In comparison with no acute toxic phe-
nomena for pure CNF, both modiﬁed-CNF samples caused
a signiﬁcant reduction in cell viability and proliferation
[51]. Interestingly, in another recent study, cationic
modiﬁed-CNF (trimethylammonium-CNF) was reported
to display a better cytocompatibility than unmodiﬁed
and anionic modiﬁed-CNF (carboxymethylated-CNF) [53].
Attributed to biosynthesis procedure during the prepa-
ration, bacterial cellulose is commonly regarded as one of
the most biocompatible material in the family of nanocel-
lulose. As shown in Table 1, no cytotoxicity for BC was
obtained according to the evaluation on osteoblast cells,
endothelial cells, and mouse feeding experiment [54–56].
Although studies conducted so far on nanocellulose
reported the absence of serious environmental and biolog-
ical concerns, research and systematic assessment of
Table 1
Toxicological evaluations of nanocellulose.
Type Toxicological experiment Conclusion Ref.
CNC  Acute lethal test  Low toxicity potential [42]
 Multi-trophic assays  Low environmental risk
 Animal experiments with fathead minnow and Zebraﬁsh
reproduction tests
 In vitro rainbow trout hepatocyte assay
 Respiratory toxicity of aerosolized CNC on the human airway
with a co-culture of human monocyte-derived macrophages,
dendritic cells and a bronchial epithelial cell line
 Low cytotoxicity [43]
 Somewhat (pro-)inﬂammatory cytokines
 In vitro gene mutations  No evidence of high toxicity [44]
 In vitro and in vivo chromosomal tests
 Skin irritation and sensitization tests
 Animal experiments with rat feeding study (28 d)
 Cytotoxicity evaluation with L929 cells  Low cytotoxicity at low CNC concentration [45]
 Cytotoxicity evaluation with nine different cell lines  No cytotoxic effects in the concentration range (0–50 lg/mL)
and exposure time (48 h)
[46]
CNF  Cytotoxicity evaluation with human monocyte and mouse
macrophages
 No evidence of inﬂammatory effects or cytotoxicity [47]
 Kinetic luminescent bacteria test for acute environmental
toxicity
 In vitro genotoxicity with enzyme comet assay  No signiﬁcant DNA damage [48]
 Neurotoxicity and systemic effects with a nematode model  Low or no cytotoxicity [49,50]
 In vitro pharyngeal aspiration study for pulmonary
immunotoxicity and genotoxicity with mice
 No DNA and chromosome damage
 Pulmonary inﬂammation
 Cytotoxicity evaluation with 3T3 ﬁbroblast cells (including the
test of cell membrane, cell mitochondrial activity and DNA
proliferation)
 No toxic phenomena for pure CNF [51]
 Somewhat cytotoxicity for modiﬁed-CNF (with PEI or CTAB
surface modiﬁcation)
 Cytotoxicity evaluation with bovine ﬁbroblasts cells  Low cytotoxicity at low CNF concentration (0.02–100 lg/mL) [52]
 Effects of gene expression in vitro  Reduction of cell viability and affection of the expression of
stress- and apoptosis-associated molecular markers at high CNF
concentration (2000–5000 lg/mL)
 Cytotoxicity evaluation with human dermal ﬁbroblasts  No evidence of cytotoxicity for pure CNF [53]
 Improved cytocompatibility of EPTMAC-modiﬁed CNF
BC  Cytotoxicity evaluation with osteoblast cells and L929 ﬁbroblast
cells
 No evidence of cytotoxicity [54]
 Cytotoxicity evaluation with human umbilical vein endothelial
cells
 No evidence of toxicity in vitro and in vivo [55]
 Animal experiment with C57/Bl6 male mouse
 In vitro immunoreactivity with human umbilical vein
endothelial cells
 Non-toxicity and non-immunogenicity [56]
 In vivo intraperitoneal injection study with BALB/c male mice
Abbreviations: PEI, polyethyleneimine; CTAB, cetyl trimethylammonium bromide; EPTMAC, glycidyltrimethylammonium chloride.
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tions, especially aimed to the effects and mechanisms of
nanoparticles aggregation in the body, and long-term
in vivo toxicity evaluation of nanocellulose. Moreover, not
only the toxicity of nanocellulose itself, what the toxicity
effects will be induced by the incorporation of nanocellu-
lose is another important issue, which indicates the eco-
toxicology of nanocellulose-based materials. Despite no
signiﬁcant cytotoxicity of nanocellulose-based materials
(generally hydrogels) in many studies [57–60], there was
also a report of negative effect on biocompatibility for
nanocellulose-based composites [61].3. Nanocellulose-based biomedical materials
The development of novel biomedical materials from
natural polymers for practical and clinical applicationsis always a most concerned topic for biologists and
material scientists. In some studies, information on nano-
cellulose and its application are mentioned as the term
‘‘biocellulose,’’ which is attributed to the unique proper-
ties and potential of nanocellulose in the study of diverse
biomedical materials. According to the report of ‘‘Future
Markets Inc.’’ in ‘‘The global market for nanocellulose
to 2017’’ published in October, 2012, there will be about
$ 97 billion estimates for medical and life sciences mar-
kets impacted by nanocellulose [12]. It is the aim of this
section to discuss the research in biomedical application
of nanocellulose with selected latest examples. From the
molecular level (cellular cultivation) to macroscopic
biomaterials (drug delivery, substitute implants, tissue
repair, regeneration, etc.), diverse studies and new
frontiers together with future strategies on nanocellu-
lose-based biomedical materials are highlighted and
remarked.
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Attributed to the properties of biocompatibility and
right mechanical properties similar to natural tissue, nano-
cellulose-based biomaterials can provide a cell-friendly
environment to encourage cells attachment and prolifera-
tion as a special tissue bioscaffold. Diverse cellular species
cultured on nanocellulose-based biomaterials have been
reported, and the forms of these materials include hydro-
gels, composites, electrospun nanoﬁbers, sponges, and
membranes. BC seems to be the most prevalent choice
for the medium of cells culture because of its low cytotox-
icity and high porosity.
Regarding CNC-based media for the culture of cells,
some studies applied conventional suspensions of unmod-
iﬁed or ﬂuorescent-modiﬁed nanocrystals as the environ-
ment for cells. From insect cells Sf9 and Hamster lung
ﬁbroblast V79, to human foreskin ﬁbroblasts, human
embryonic kidney cells HEK-293 and human lung cell, no
signiﬁcant cytotoxicity to various cell models was found,
and promising cellular uptake and proliferation were
reported in these studies [43,62–64]. Using a spin-coating
method, Dugan et al. prepared submonolayer ﬁlm with ori-
ented surfaces of adsorbed CNC. Due to the shape and
nanoscale dimensions of CNC, murine myoblasts cells
C2C12 adopted increasingly oriented morphologies in
response to more densely adsorbed and oriented nanocrys-
tals surface. With a mean feature height of only 5–6 nm,
CNC surface presented the smallest features to induce con-
tact guidance in skeletal muscle myoblasts [65,66].
Recently, electrospun nanoﬁbers based on CNC, bearing
suitable mechanical property, in vitro degradation and
basic cytocompatibility, were proved to be promising bio-
nanocomposite scaffolds for cell culture. It was reported
that electrospun maleic anhydride-grafted poly(lactic acid)
nanoﬁbers reinforced with CNC can be the supporting scaf-
folds to culture the human adult adipose derived mesen-
chymal stem cells (hASCs) and promote cell proliferation.
Low CNC concentration effectively improved the thermal
stability and mechanical properties of scaffolds, but not
signiﬁcantly caused any cytotoxic effect on hASCs prolifer-
ation within 7 days [67]. Another study reported the appli-
cation of all-cellulose scaffold materials (CNC/cellulose) to
culture cells, and the inﬂuence of CNC orientation in scaf-
folds to cell growth was investigated. Fig. 3(a and a0) pre-
sents confocal laser scanning microscope (CLSM) images
of Human dental follicle cells (hDFCs) cultured on electro-
spun CNC/cellulose nanoﬁbers for 3 and 7 days. It was
shown that CNC can well dispersed in electrospun scaffolds
and achieve considerable orientation along the long axis
direction. Cultured cells can proliferate rapidly not only
on the surface but also deep inside the scaffolds. More
interestingly, the aligned nanoﬁbers of CNC/cellulose
exhibited a strong effect on directing cellular organization
[68].
Under controlled concentrations, CNF aqueous suspen-
sions can spontaneously form hydrogels to provide suit-
able environment with required mechanical support for
cell growth and differentiation. It was reported that CNF
hydrogels can promote the cellular differentiation of the
human hepatic cell lines (HepG2 and HepaRG), andinduced the spheroid formation of cells [69]. A novel scaf-
fold composed of natural polymers was reported to culture
NIH3T3 ﬁbroblast, involving the components of pectin,
carboxymethyl cellulose and CNF [70]. Recently, highly
porous and biomimetic nanocomposites that allow for
modulating the growth of L-929 ﬁbroblasts were prepared
by incorporating calcium peroxide (CaO2) and catalase into
CNF matrix. Fig. 3(b and b0) shows CLSM images of L-929
ﬁbroblasts cultured on pristine CNF and CNF modiﬁed with
15 wt% calcium peroxide/catalase composite scaffolds. The
addition of CaO2 and catalase induces the presence of
hydrogen peroxide (H2O2) or oxygen (O2), which affected
the survival of cells. Three-dimensional porous morphol-
ogy of CNF-based scaffolds both facilitated the diffusion
of generated gases and provided great niches for cell
growth. It was reported that due to the generation of
H2O2, cell attachment decreased, and cell proliferation
was delayed; while the generation of O2 played a useful
role in supporting cell proliferation [71].
Various BC-based bioscaffolds for the application of cel-
lular culture can be mainly divided into three aspects,
which are BC pellicle/membrane scaffolds, BC/matrix
biocomposite scaffolds, and surface-modiﬁed BC pellicle
scaffolds. Several latest studies focused on pure BC as scaf-
folds for supporting cellular adhesion and proliferation.
Favi et al. investigated BC as a hydrogel scaffold for the cul-
ture of equine-derived bone marrow mesenchymal stem
cells (EqMSCs). As shown in Fig. 3(c and c0), BC hydrogels
were cytocompatible, and signiﬁcantly supported cellular
adhesion and proliferation. The cells seeded on the BC
hydrogel were observed to be viable and metabolically
active [72]. Park et al. investigated the alteration of func-
tion of human umbilical vein endothelial cells treated with
a,b-unsaturated aldehyde on BC scaffold. The study indi-
cated that a,b-unsaturated aldehydes in cigarette smoke
induce altered endothelial cell functions including mor-
phology, adhesion, proliferation, viability, and growth on
BC [73]. Another work presented a cellular building unit
made from microstrand-shaped BC covered with mamma-
lian cells. By folding or reeling the building unit, the multi-
ple shapes of millimeter-scale cellular constructs (coiled
and ball-of-yarn-shaped structures) were investigated.
Histological analysis of the cellular constructs indicated
that the BC microstrand served as a pathway of nutrition
and oxygen to feed the cells in the central region [74].
Recently, the laser patterning post-processing was used
on BC to solve the limitation of small and heterogeneous
pore size for the ingrowth of cells. After laser perforation,
BC hydrogels displayed high biocompatibility and the
resulting channels supported migration, matrix production
and phenotypic stabilization of bovine chondrocytes,
which qualiﬁed perforated-BC as a sustainable scaffold
for cell ingrowth [75].
Regarding the materials used for the BC/matrix scaffold
systems, chitosan, agarose, alginate, collagen, gelatin, poly-
pyrrole, and poly(3-hydroxybutyrate-co-4-hydroxybuty-
rate) [P(3HB-co-4HB)] have been studied as matrices to
culture cells. Polypyrrole was in situ polymerized onto
the surface of BC to produce the BC/polypyrrole membrane
scaffold, and performed the seeding of PC12 rat neuronal
cells. Conductive polypyrrole coating on BC acted as an
Fig. 3. Confocal laser scanning microscope (CLSM) images of nanocellulose bioscaffolds for cell culture. Human dental follicle cells (hDFCs) cultured on
electrospun CNC/cellulose nanoﬁbers for (a) 3 days, (a0) 7 days; scale bar = 50 lm (adapted with permission from [68]). L-929 ﬁbroblasts cultured for 7 days
on (b) pristine CNF, (b0) CNF/15 wt% calcium peroxide/catalase composite; scale bar = 40 lm (adapted with permission from [71]). Equine-derived bone
marrow mesenchymal stem cell (EqMSCs) cultured on BC hydrogels for (c) 2 days, (c0) 14 days; scale bar = 50 lm (adapted with permission from [72]).
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cial for the regulation of cell activity through electrical
stimulations [76]. Incorporated with gelatin or hydroxyap-
atite (Hap) to enhance the bioactivity, Wang et al. devel-
oped a porous BC membrane with regular vertical pore
arrays via a laser patterning technique. Chondrogenic rat
cells were cultured on these membrane scaffolds, and the
scaffolds well supported the attachment and proliferation
of cells together with the preservation of cellular viability
[77]. Another study prepared BC-biocomposite scaffolds
by freeze-drying using polymeric P(3HB-co-4HB) as matrix
and triﬂuoro-acetic acid as co-solvent. Chinese hamster
lung ﬁbroblast cells were incubated on this composite scaf-
fold for 48 h, which exhibited the capability of cell adhe-
sion and proliferation, as well as better biocompatibility
than pure P(3HB-co-4HB) scaffold [78].
To further enhance cell attachment on BC-based bio-
scaffolds, surface modiﬁcations can be performed, such as
protein or peptide coatings, plasma treatment, surface sul-
fation or phosphorylation. Shi et al. prepared a BC scaffoldcoated with bone morphogenetic protein-2 (BMP-2). The
alkaline phosphatase activity assays indicated that BC
had a good biocompatibility and induced the differentia-
tion of mouse ﬁbroblast-like C2C12 cells into osteoblasts
in the presence of BMP-2 in vitro. Within a certain range
(0–3 mg/scaffold), the osteogenic activity of induced oste-
oblasts was positively correlated to the concentration of
BMP-2. In vivo subcutaneous implantation studies further
showed that BC scaffolds modiﬁed with BMP-2 promoted
more bone formation and higher calcium concentration
than the BC scaffolds alone at 2 and 4 weeks [79]. Another
surface modiﬁcation strategy using plasma treatments (O2,
N2, or CF4 plasmas) on BC reported altered changes of sur-
face property involving more hydrophilic BC with O2 or N2
plasma treatment, and hydrophobic BC with CF4 plasma
treatment. Furthermore, different surface plasma treat-
ments on BC scaffolds will provide distinct effects for the
adhesion of L-929 ﬁbroblast and Chinese hamster ovary
cell line. It was reported that the cell adhesion and prolif-
eration of both cells was signiﬁcantly improved on
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liferation for O2 or N2-modiﬁed BC scaffolds was reported
in comparison with pristine BC scaffold [80]. Kuzmenko
et al. reported a universal method of protein bioconjuga-
tion on BC scaffolds in order to increase cell adhesion.
The surface of BC scaffolds was modiﬁed with two pro-
teins, ﬁbronectin and collagen type I, through the biocon-
jugation applying 1-cyano-4-dimethylaminopyridinium
(CDAP) tetraﬂuoroborate as the intermediate catalytic
agent. Effective promotion of cell attachment by CDAP
treatment to BC scaffolds was shown for human umbilical
vein endothelial cells and the mouse mesenchymal stem
cells [81]. Recently, the surface oxidized modiﬁcation of
BC with TEMPO-C6 or dialdehyde-C2, 3 was also reported
to promote the adhesion and proliferation of cells [53,82].
3.2. Drug excipient and drug delivery
Possessing excellent compaction property, cellulose
has a long history of application in the pharmaceutical
industry, in particular as pharmaceutical excipients to
condense drug-loaded matrices as suitable tablets for oral
administration. Despite an extended history of use in tab-
leting, there is still continuing research into the use of
cellulose with new types of cellulose (viz. nanocellulose)
in advanced drug-loaded systems whereby the rate of
tablet disintegration as special excipients, or prolonged
drug release as novel drug carriers. As a drug delivery
excipient, Burt et al. investigated the capability of pure
CNC to bind water soluble antibiotics (tetracycline and
doxorubicin), and the potential of cationic-CNC to bind
nonionized hydrophobic anticancer agents (docetaxel,
paclitaxel, and etoposide) [83]. Besides direct use as
excipient, CNC can also be used as co-stabilizer to
improve the physicochemical and ﬂow properties of poly-
meric excipients. Acrylic beads prepared via emulsion
polymerization using CNC as co-stabilizer were proved
to be a suitable excipient. The presence of CNC affected
positively the size and size distribution of the bead excip-
ient, which formed a stable structure together with low
ﬂow time and reduced cotangent of angle [84]. In another
work, investigating spray-drying treatment on tablets,
CNF exhibited a better ability to pack with lower powder
porosity than commercial microcrystalline cellulose,
which indicated novel spray-dried CNF excipient for tab-
let production [85]. With the same technique of spray-
drying, BC was ﬁlm-coated on tablets, and provided soft,
ﬂexible, and foldable nanocellulose ﬁlms, which exhibited
better mechanical properties in comparison with tradi-
tional Aquacoat ECD materials (polymeric materials com-
posed of 30 wt% aqueous ethylcellulose dispersion)
materials [86].
Common forms of nanocellulose-based drug carriers
can be mainly divided into three aspects, viz. microspheres
(or microparticles), hydrogels (or gels), and membranes (or
ﬁlms). Table 2 summarizes various drug carrier systems
based on nanocellulose. It was reported that solid carriers
formed from nanocellulose and different matrices spatially
trapped drug molecules, and imparted the regulation of
drug release. Lin et al. developed a pH-sensitive CNC/
sodium alginate microsphere-based controlled releasesystem for drug delivery. The presence of CNC in algi-
nate-based microspheres showedmore consistent swelling
patterns, higher encapsulation efﬁciency, and promising
sustained release proﬁles of the drug [87]. Regarding the
application of nanocellulose in the fabrication of hydrogels,
CNC was chemically grafted with cyclodextrin and partici-
pated in the architecture of hydrogels via in situ inclusion
interactions. The drug release study revealed the perfor-
mance of hydrogels as drug carriers for the in vitro release
of doxorubicin and exhibited the behavior of prolonged
drug release with special release kinetics and mechanisms,
which were the ‘‘obstruction effect’’ and ‘‘locking effect’’
attributed to the good dispersion of the nanoparticles
and the formation of a rigid network of CNC [91]. Kolakovic
et al. reported the application of CNF ﬁlms for long-lasting
sustained drug delivery by a ﬁltration processing. The drug
release studies showed generally sustained drug release
over periods of three months for model drugs. Interest-
ingly, with the same CNF drug carriers, the release of indo-
methacin showed diffusion limited release, while
itraconazole and beclomethasone showed almost zero-
order release kinetics. The dependence of model drug used
for release kinetics was attributed to the different drug sol-
ubilities in the dissolution medium, and the varied effects
of drug binding to the CNF chains [100]. In another study,
Valo et al. coupled a genetically engineered hydrophobin
fusion protein with cellulose binding domains (CBD) and
coated itraconazole drug nanoparticles for subsequent
binding to CNF. Hydrophobin or hydrophobin-double CBD
was selected to facilitate drug molecules binding to CNF
matrix. The presence of CNF provided protection for drug
nanoparticles and notably increased formulation storage
stability during the formulation process and storage. It
was reported that in the carrier system containing
hydrophobin-coated CNF, drug nanoparticles around
100 nm could be stored for more than ten months [89].
Regarding the studies of BC in drug delivery, Huang et al.
recently investigated the effects of BC membranes for the
delivery of berberine hydrochloride and berberine sulfate
in comparison with commercial tablet. It was reported that
BC is a promising drug carrier to signiﬁcantly extend the
release duration of model drugs [104]. Müller et al. per-
formed BC as a hydrogel carrier for bovine serum albumin
as the model drug. It was shown that freeze-dried BC sam-
ples exhibited lower uptake of albumin than native, never-
dried BC and that release of the model drug was a result of
both diffusion- and swelling-controlled processes. Further
studies using luciferase as the model protein indicated that
the three-dimensional structure and activity of this protein
can be preserved during the binding and release from BC
hydrogels [94].
Unlike traditional trapping strategy, some researchers
recently attempted to directly attach drug molecules on
nanocellulose, which was performed using covalent cou-
pling between modiﬁed nanocellulose and drug molecules.
With a series of oxidation, reductive-amination, and ester-
iﬁcation reactions in aqueous media, a novel CNC-based
delivery system attached to the syringyl alcohol linker
through a c-aminobutyric acid spacer molecule can be pro-
duced, on which small model amine drugs (e.g., phenylpro-
panolamine) can be covalently connected [110]. Similarly,
Table 2
Drug carrier systems based on nanocellulose.




CNC EA; MMA; BMA Propranolol hydrochloride 12 h in pH 6.8 PBS – [84]
Sodium
alginate





CNF – Indomethacin; nadolol; atenolol;
metoprolol tartrate; verapamil;
ibuprofen




Hydrophobin Itraconazole 90 min in pH 1.2 NaCl/HCl
solution
– [89]
Suspension CNC CTAB Paclitaxel; docetaxel; DOX; TET;
etoposide
1–4 d in PBS – [83]
Chitosan
oligosaccharide










Bovine serum albumin 20 h in pH 7.4 PBS – [92]
Regenerated
cellulose
Bovine serum albumin 48 h in simulated body ﬂuid Fickian diffusion
law
[93]
BC – Bovine serum albumin 48 h in pH 7.4 PBS Ritger-Peppas
equation
[94]
– Collagen; hyaluronan; growth
factors
36–96 h in PBS – [95]











CNF – Paracetamol 5–10 min in water – [85]
– Lysozyme 10 h in pure water or water/
ethanol solution
Fick’s second law [98]
– Caffeine 9 h in water Higuchi equation [99]
– Indomethacin 30 d in pH 5.0 phosphate
buffer
Higuchi equation [100]
Itraconazole 90 d in pH 1.2 NaCl/HCl
solution
Beclomethasone dipropionate 90 d in water
BC – Paracetamol 2 h in pH 5.8 PBS – [86]
– Lidocaine 7 h in pH 7.4 PBS – [101]
– Lidocaine; ibuprofen 8 h in pH 7.4 PBS Fickian diffusion
law
[102]
– Caffeine 15 h in pH 7.4 PBS – [103]
– Berberine hydrochloride,
berberine sulfate
24 h in pH 2.1 HCl or H2SO4
















Columbia blue 48 h in water Higuchi equation [107]
Hordein/zein Riboﬂavin 24 d in pH 7.4 PBS – [108]
Aerogel CNF – Beclomethasone dipropionate 700 min in pH 8.0 SDS solution – [109]
Abbreviations: BMA, butylmetacrylate; CTAB, cetyl trimethylammonium bromide; DOX, doxorubicin hydrochloride; EA, ethyl acrylate; MMA, methyl-
methacrylate; TET, tetracycline hydrochloride; PBS, phosphate-buffered solution; SDS, sodium dodecyl sulfate.
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CNC, hydrophobic solid drug nanoparticles can be
adsorbed by the packed protein ﬁlm on nanocellulose
and can improve the long-term stability of drugs under
physiological condition [111].
The use of natural nanocellulose to deliver drugs is an
attractive idea, but many issues are still under investiga-
tion, especially regarding the inﬂuence and regulation ofdrug release, interactions between drug molecules and
nanocellulose [112], as well as possible reduction or
destruction of drug activity and structure. Recently, it
was reported that the surface charges on nanocellulose
(TEMPO-oxidized negatively charged CNF) presented the
adverse impact on the chemical stability of drug molecules
(aspirin), which will accelerate the decomposition of drugs
[113].
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To overcome the problem of instability and rapid loss
of catalytic activity during the operational and storage
periods resulting from autolysis, unfolding, and aggrega-
tion of enzyme and protein, the immobilization of
enzyme/protein on carriers has been considered as a
powerful technique in diverse ﬁelds ranging from food
technology to biomedical and biosensor engineering. An
ideal carrier material for enzyme/protein immobilization
should be biocompatible without compromising the pro-
tein structure and biological activity. Furthermore, this
carrier material should be easily processed to enhance
the enzyme/protein loading and activity as well as the
stability in both operation and storage. As a nontoxic,
noncarcinogenic, biocompatible, and in no way injurious
in the biological environment material, nanocellulose
meets the rigid medical requirements of suitable carrierTable 3
Surface immobilization of enzyme or protein on nanocellulose.











CNF Alkaline phosphatase; anti-hydrocortisone ant
Avidins
Physical adsorption CNC Heptapeptide
Diblock protein (Elastin-co-Cartilage oligomeri
matrix)
CNF Pancreatic serine protease trypsin
Antihuman IgG antibody
Human immunoglobulin G (IgG)
Laccase
Lipase




Abbreviations: Poly(AMA-co-HEMA), poly(2-aminoethyl methacrylate hydrochlorfor the immobilization of enzyme and protein. Another
key point in enzyme/protein immobilization is the selec-
tion of the immobilization method, such as adsorption,
entrapment, or covalent binding on carrier material.
Available hydroxyl groups and possible negative charges
(CNC and CNF) on the surface of nanocellulose provide
the possibility of enzyme/protein immobilization on the
basis of chemical conjunction and electrostatic adsorp-
tion. Table 3 summarizes recent studies on surface immo-
bilization of enzyme or protein on nanocellulose on the
basis of different strategies (chemical binding or physical
adsorption). Covalent immobilization of enzyme/protein
on nanocellulose can provide signiﬁcantly high enzyme/
protein loading and excellent stability, but always treated
with complicated chemistry procedure. Physical approach
is simple, cheap, and allows better preservation of the ori-
ginal structure of enzyme/protein, but with limited load-
ing and efﬁciency of immobilization.Speciﬁc procedure Ref.
 Esteriﬁcation [114]
 Coupling with enzyme
 Surface activation [115]
 Coupling with protein
 Surface deposited gold nanoparticles [116]
 Coupling with enzyme
 Polyetherimide surface cationization [117]
 Deposited gold nanoparticles
 Coupling with enzyme
 Surface TEMPO-oxidation [118]
 Coupling with peptides
 Esteriﬁcation with glycine [119]
 Coupling with elastase
 Embedment of Fe3O4 and Au on the surface [120]
 Surface activation
 Coupling with enzyme
 Azide modiﬁcation on CNC reducing ends [121]
 Acetylene modiﬁcation on b-Casein
 Click reaction for the coupling of protein
ibody  Amine/epoxy/carboxylic acid modiﬁcation [122]
 Coupling with protein
 Surface TEMPO-oxidation [123]
 Coupling with protein
 Adsorption and identiﬁcation of peptide [124]
c  Copolymerization of diblock proteins [125]
 Adsorption of proteins
 Synthesis of nanocellulose-based hydrogel [126]
 Entrapment of protein
 Oxidation and activation [127]
 Adsorption of protein
 Surface grafting from poly(AMA-co-HEMA) [128]
 Adsorption of modiﬁed peptide (acetylated-
HWRGWVA)
 Coupling with protein
 Adsorption of enzyme [129]
 Adsorption of enzyme [130]
 Surface phosphorylation [131]
 Adsorption of protein
 Surface quaternary ammonium [132]
 Adsorption of protein
 Preactivation [133]
 Adsorption of enzyme
 Surface modiﬁcation with dye molecule [134]
 Adsorption of enzyme
ide-co-2-hydroxyethylmethacrylate).
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surface of CNC provide the possibility of enzyme/protein
immobilization on the basis of chemical conjunction and
electrostatic adsorption. Regarding the chemical strategy,
some studies directly immobilized enzyme/protein on
CNC with chemical grafting, such as immobilization of
lysozyme on amino-glycine-CNC with carbodiimide-acti-
vation coupling reaction [114]; or peroxidase on CNC with
the activation of cyanogen bromide treatment [115].
Another approach consists in functionalizing with smaller
nanoparticles (generally gold nanoparticles, Au), and then
realizing the immobilization of enzyme/protein on CNC
with the aid of inorganic nanoparticles. Luong et al. inves-
tigated CNC/Au as a catalytic platform for enzyme immobi-
lization, which exhibited signiﬁcant biocatalytic activity
and preservation of original activity. The recovered speciﬁc
activities were about 70% and 95% for CGTase and alcohol
oxidase enzymes, respectively [116]. More complicated
carrier based on CNC/PEI/Au was developed to immobilize
glucose oxidase enzyme [117]. Mahmoud et al. developed
a special nanocomposite consisting of magnetite nanopar-
ticles (Fe3O4) and Au nanoparticles embedded on CNC as a
magnetic support for covalent conjugation of papain and
facilitated the recovery of immobilized papain [120]. The
conjugated material retained high enzyme activity and
good stability and reusability. Based on the similar strategy
of enzyme/protein immobilization, labeled DNA or enzyme
was immobilized on CNC as a bioprobe, and used for the
identiﬁcation or recognition of target DNA sequence,
enzyme molecules, or as the platform for immunoassays
and diagnostics [135,136]. Edwards et al. reported a color-
imetric approach for the detection of human neutrophil
elastase (HNE) using peptide conjugated CNC [119].
Recently, the immobilizing effects of CNC and the diblock
proteins bearing two different self-assembling domains
[elastin (E) and the coiled-coil region of cartilage oligo-
meric matrix protein (C)] were investigated. It was
reported that the protein CE with prevalent displaying of
the E domain interacted more with CNC leading to a stron-
ger network, while the protein EC, which is predominantly
C-rich on its surface, did not interact as much with CNC.
This study suggested that the surface characteristics of
the protein polymers, due to folding and self-assembly,
were important factors for the interactions with CNC, and
therefore of signiﬁcant inﬂuence on the overall immobili-
zation efﬁciency [125]. With the purpose of identifying
speciﬁc crystalline region of CNC for the immobilization
of enzyme or protein, Guo et al. reported the phage display
technology involving biopanning assays and enzyme-
linked immunosorbent assay to investigate this binding
property. A model of consensus peptide was efﬁciently
immobilized on CNC, and the analysis indicated that pep-
tide exhibited a bent structure when bound, allowing the
Y5 amino acid to form a CH/p stacking interaction and H-
bond with the glucose ring of cellulose [124].
Regarding chemical conjunction of enzyme or protein
on CNF, some studies directly immobilized enzyme/protein
macromolecules on CNF with grafting reactions, such as
avidins binding on oxidized CNF [123], protein immobili-
zation of alkaline phosphatase and anti-hydrocortisone
antibody on amine, epoxy, and carboxylic acid modiﬁedCNF [122]. More studies reported the physical adsorption
to immobilize enzyme or protein on CNF. In order to
enhance the interactions of enzyme/protein immobiliza-
tion on CNF, some studies attempted to modify the surface
of CNF before the entrapment of enzyme/protein mole-
cules, such as oxidation and activation pretreatments
[127] and surface polymeric grafting [128].
The immobilization of enzyme/protein on BC is mainly
achieved by physical interactions between BC and original
enzyme/protein molecules, such as electrostatic adsorp-
tion of proteins on modiﬁed BC with surface phosphoryla-
tion or quaternary ammonium [131,132]. Recently, the
properties and feasibility of BC membrane for the immobi-
lization of glutamate decarboxylase was reported. With a
pre-activation treatment followed by protein adsorption,
immobilized glutamate decarboxylase on BC membrane
exhibited good retention of protein activity (89.17%), least
leakage, and high stability (5% loss), which was associated
to the porosity of the carrier material [133].
3.4. Substitutes/medical biomaterials
Promising mechanical properties and good biocompati-
bility of nanocellulose promote its research and develop-
ment as substitute/medical biomaterial, such as the
replacement of blood vessel (vascular graft), soft tissue,
and nucleus pulposus. The studies of nanocellulose as
blood vessel replacement are most attracting and fruitful,
as reported from the effects in various animal experiments
before clinical research. Regarding the studies on nanocel-
lulose as soft tissue and nucleus pulposus, most reports are
still in the fundamental stage, and mainly focus on the
comparison of different properties between nanocellu-
lose-based materials and real organs.
3.4.1. Blood vessel replacement
One of the most common treatments to cardiovascular
disease is the coronary bypass graft surgery, which is per-
formed to supply blood to the heart tissue with a suitable
blood vessel replacement. Possessing good mechanical
strength (a burst pressure of up to 880 mmHg) and blood
biocompatibility, it is possible to develop nanocellulose
(especially for BC) as material for artiﬁcial tubes used as
potential replacement of small (<4 mm) or large (>6 mm)
size vascular grafts. The team of Dieter Klemm (University
Jena and Polymer Jena, Germany) was the ﬁrst research
organization to investigate and apply artiﬁcial vascular sub-
stitute obtained with biomaterials from BC. They have dis-
cussed the application of BC as blood vessel replacement
in some publications [137–139], and especially described
a clinical product named BActerial SYnthesized Cellulose
(BASYC) with highmechanical strength in wet state, enor-
mous water retention property, and low roughness of inner
tube surface. It is reported that BASYC from BC has been
successfully used as the artiﬁcial blood vessel in rats and
pigs for microsurgery [140,141]. In comparison with con-
ventional synthetic vascular graft materials, e.g. polyester
(Dacron) and ePTFE, biosynthetic BC tubes can be suitable
for small diameter (<4 mm) vascular conduits, and restrain
the phenomena of thrombus induction and stenosis. BASYC,
BActerial SYnthesized Cellulose (BC tubes) with different
Fig. 4. Examples of substitutes from nanocellulose. (a) BASYC, BActerial SYnthesized Cellulose (BC tubes) with different dimensions (adapted with
permission from [145]). (b) Vascular prostheses made of CNF-polyurethane placed between the brachiocephalic trunk and the right common carotid artery
in male patient (adapted with permission from [146]). (c) Comparison between pig meniscus (left) and BC hydrogel (right) (adapted with permission from
[147]). (d) Negative silicone mold used to guide the bacteria during the bacterial culture to reproduce the large-scale features of the outer ear (left); and 3D
BC implant prototype (1% effective cellulose content) produced in the shape of the whole outer ear according to the 3T MRI scanning technique (right)
(adapted with permission from [148]).
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ties and biology evaluation of BC tubes as blood vessel
replacement have been investigated, involving the issues
of BC biomaterial-induced coagulation [142], cell attach-
ment, proliferation, viability and invasion [143], hemody-
namic analysis and microcirculatory evaluation [144], etc.
Different from BC biosynthetic procedure, it is impossi-
ble to directly fabricate the tubes from CNC and CNF.
Therefore, the development of CNC or CNF-based blood
vessel replacement commonly includes the use of a matrix
material. Recently, Brown et al. reported the synthesis of
CNC/ﬁbrin biocomposites for the potential application of
small-diameter replacement vascular graft. CNC was cova-
lently grafted on ﬁbrin matrix, and provided nanorein-
forcement in terms of strength and elasticity to the
composites [149]. However, this material has not been
tested in vivo. Novel biomaterials from polyurethane rein-
forced with CNF have been reported to be potentially used
as vascular replacement. The presence of CNF in polyure-
thane improved the elastic properties of the material, cou-
pled with low thrombogenicity and exceptional physical
and mechanical properties. CNF/polyurethane biomateri-
als, with a wall thickness of 0.7–1.0 mm, were applied as
vascular prostheses between the brachiocephalic trunk
and the right common carotid artery in a 26-year-old male
patient with multiple endocrine neoplasia 2B (Fig. 4(b)). It
is a pity that no further effect of this CNF/polyurethane bio-
material in clinical study was reported.
Based on decades of research, it is successful to produce
nanocellulose-based materials for blood vessel
replacement under proper control of the biotechnological
formation. However, detailed in vivo characterization ofthe performance of these nanocellulose implants (in large
animal and even human body studies) are still required,
addressing in particular their long-term stability and suit-
ability to replace small-caliber blood vessels without sig-
niﬁcant thrombogenicity, study of compliance between
the graft and the surrounding native vessels, together with
the postoperative complications
3.4.2. Soft tissue–ligament, meniscus, and cartilage
replacements
The design and fabrication of materials suitable for soft
tissue replacement are important aspects of the biomedical
application. The demand for biomaterials to be used for
soft tissue replacement should not only provide similar
mechanical properties as the tissue it replaces, but also
improve lifespan, biocompatibility, durability, and low
degree of calciﬁcation. Using a double-network method,
BC/polyacrylamide (PAAm) gels can be synthesized by
combining BC gel as the ﬁrst network, and PAAm as the
second network in the presence of a crosslinker. The BC/
PAAm gels presented high elongation and high tensile frac-
ture stress (40 ± 10 MPa), which was similar to the tensile
fracture stress of ligament (38 ± 10 MPa), and could be
potentially used as ligament replacement [150]. Mathew
et al. also reported the preparation of CNF and CNF/colla-
gen composites for potential ligament. Both composites
exhibited mechanical properties and stress relaxation
behavior comparable to those of natural ligaments and
tendons. Further in vitro biocompatibility study on these
composites showed a positive response concerning
adhesion/proliferation and differentiation for both human
ligament and endothelial cells [151,152].
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of BC gel with traditional collagen meniscal implant mate-
rial and real pig meniscus. It was reported that the Young’s
modulus of BC gel is similar to the one of pig meniscus, and
ﬁve times higher than the one of collagen material. The
results of promising cell migration and controlled menis-
cus shape (as shown in Fig. 4(c)) indicated that BC can be
an attractive material as meniscus implant [147]. Another
study investigated the friction and wear behaviors of BC
pellicles against bovine articular cartilage. The tribological
assessment of the sliding pairs for BC was performed using
reciprocating pin-on-ﬂat tests. Due to the wear mechanism
involving high plastic deformation combined with the for-
mation of tribological rolls at the contact interface, BC bio-
materials possessing low friction coefﬁcient values (about
0.05) and preservation of the mating surfaces can be
obtained. This BC biomaterial was reported to be a poten-
tial replacement of artiﬁcial cartilage for articular joints
[153]. Recently, based on the 3T MRI scanning technique,
an ear-shaped BC prototype material was produced from
a negative ear mold, as shown in Fig. 4(d). Meanwhile, it
was reported that the mechanical properties of BC bioma-
terials can be regulated by the effective cellulose contents.
This study proved that BC is a promising material to reach
mechanical properties of ear cartilage replacement, and
can be produced in patient-speciﬁc ear shapes [148].
3.4.3. Nucleus pulposus replacement
Nucleus pulposus is a gelatinous core inside two verte-
bral bodies for intervertebral disks, which is important to
provide ﬂexibility and dissipate the stresses acting on the
spine. It is reported that about 80% of the world population
suffers from back pain, and in 75% of cases this is a direct
consequence of degenerative processes of the disc, in par-
ticular nucleus pulposus degeneration. In recent studies, a
biocomposite hydrogel with carboxymethylated CNF was
prepared by UV polymerization of N-vinyl-2-pyrrolidone
for the replacement of native human nucleus pulposus.
The biocomposite hydrogel containing 0.4% v/v of carbo-
xymethylated CNF with DS of 0.17 presented a close
behavior to native nucleus pulposus, such as low strain
values after cyclic compression tests, and similar relaxa-
tion properties [154]. Further study demonstrated that this
biocomposite hydrogel can act as a potential nucleus pul-
posus implant attributed to its adequate swelling ratio
and improved mechanical properties, which may be bene-
ﬁcial to restore the annulus ﬁbrosus loading and the height
of the intervertebral discs [155].
3.5. Advanced nanomaterials for tissue repair, regeneration
and healing
Tissue repair and regeneration is the process of renewal,
restoration, and growth thatmakes the function of diseased
and damaged cells, organs, and tissues resilient to natural
ﬂuctuations. From bacteria to humans, all species have spe-
ciﬁc ability of tissue repair and regeneration. Different from
the effects of substitute implants, the behavior of tissue
repair and regeneration for organism inherently originates
from the individual self. Although no property of tissue
regeneration or repair for nanocellulose itself, it can providea nontoxic and biocompatible platform to cover growth fac-
tors or cells, which will activate and accelerate the process
of tissue repair and regeneration. Most studied applications
of nanocellulose-based biomaterials for tissue repair,
regeneration, and healing are skin tissue repair (wound
dressings) and bone tissue regeneration and healing.3.5.1. Skin tissue repair and wound healing
Regarding skin repair materials (also called wound
dressings), an important characteristic is their ability to
absorb exudate during the dressing process, and its
removal from a wound surface after recovery. The draw-
backs of traditional skin tissue repair materials, e.g. gauze,
are their strong permeability, which will cause the tight
adhesion of repair materials on the desiccated wound
surface and thus induce new trauma on removal [156].
Considering its signiﬁcant biological properties, interest
on nanocellulose (especially BC) for novel wound care
has steadily increased. BC skin tissue repair biomaterials
can be fabricated by a multilayer fermentation method,
which showed low cytotoxicity and good proliferation of
human adipose derived stem cells. According to the animal
experiments and histological examinations, more rapidly
fresh tissue regeneration and signiﬁcant capillary forma-
tion in the wound area with BC-based biomaterials were
reported compared with commercial dressings [157,158].
In another study, the effects of BC as wound dressing
material were evaluated on animal experiments (male 6-
week-old Sprague-Dawley rats), which proved that the
presence of BC can promote wound healing by accelerating
contractions through the accumulation of extracellular
matrix [159]. Some studies also attempted to combine
nanocellulose with various natural matrices in order to
develop enhanced biocomposites for potential skin tissue
repair materials, such as collagen [160], gelatin [161], algi-
nate [162], chitosan [163], cotton gauze [164], poly(ethyl-
ene glycol) [165], and poly(vinyl alcohol) [166].
BC-based biomaterials have been reported to be applied
in clinical practice. Non-healing lower extremity ulcers
were treated with a BC wound dressing. The time required
for 75% reduction in wound size was compared for 11
chronic wounds with and without the presence of BC.
The mean period of wound healing without the addition
of BC was 315 days (95% conﬁdence interval (CI): 239–
392 days), while with the incorporation of BC to these
chronic wounds, the mean time of wound healing reduced
to 81 days (95% CI: 50–111 days). In this case, the use of BC
wound dressing was reported to signiﬁcantly shorten the
time for the tissue repair of non-healing lower extremity
ulcers compared with standard care [167]. In the studies
of clinical effects of BC for skin tissue repair, clinical trials
were conducted on 34 patients suffering from severe ther-
mal burns covering 9–18% of the total body surface area, in
which 22 of the patients received BC as testing group. It
was reported that the adherence of BC membrane to the
wound surface was excellent in avoiding dead spaces,
which indicated that the application of BC dressing in the
treatment of partial thickness burns to promote a favorable
environment for fast wound cleansing and rapid healing
[168]. Similar conclusions on BC improving skin tissue
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lications [169,170].
On the basis of fundamental researches on the develop-
ment of BC-based skin repair materials, some companies
have launched several commercial products in wound
healing system. BioFill Produtos Bioetecnologicos (Curitiba,
PR Brazil) developed a series of products based on BC,
including Bioﬁll and Bioprocess (used in the therapy of
burns, ulcers as temporary artiﬁcial skin), and Gengiﬂex
(applied in treatment of periodontal diseases). Another
company, Xylos Corporation in the US, has developed
several medical devices using BC since 1996. The XCell
family offered by Xylos Corporation has been marketed
in the US since 2003. Unlike BC dressings manufactured
by Bioﬁll, the Xcell product is claimed to have a dual-
function of both hydration and absorption to maintain
the ideal moisture balance [171].
3.5.2. Bone tissue regeneration and healing
Developing effective bone regeneration therapy is a
long-term attracting clinical topic. Bone loss caused by
trauma, neoplasia, reconstructive surgery, congenital
defects, or periodontal disease is a major health problem
worldwide. As mentioned in the Section 3.1, nanocellulose
and its biocomposites have been proved to be the promis-
ing scaffolds for the culture of various cells, including
osteoblast and chondroblast, which indicates that nanocel-
lulose-based materials have the potential for bone tissue
regeneration and healing. However, studies on nanocellu-
lose for bone tissue regeneration and healing applications
are still at the fundamental stage, and only few publica-
tions report the practical effects on animal experiments.
A membrane composed of BC and hydroxyapatite was
developed as biomaterial for potential bone regeneration,
which showed the promotion of growth of osteoblast cells,
high level of alkaline phosphatase activity, and greater
bone nodule formation. The better osteoblasts adhesion,
proliferate and mineralization from BC/hydroxyapatite
biomaterials were expected to facilitate quick regeneration
of bone tissue [172]. Saska et al. further evaluated the bio-
logical properties and practical effects of BC/hydroxyapa-
tite membranes for bone regeneration with in vivo
animal experiments. The biomaterials were embedded to
improve noncritical bone defects in rat tibiae at 1, 4, and
16 weeks. Low crystallinity hydroxyapatite crystals pre-
sented a Ca/P molar ratio of 1.5, similar to physiological
bone. The BC/hydroxyapatite membranes were proved to
accelerate new bone formation at the defect sites for bone
regeneration in rat tibiae according to in vivo tests for
4 weeks [173]. Recently, goat bone apatite was reported
to be introduced in BC for the fabrication of novel bone
repair biomaterials, which can stimulate bone cell prolifer-
ation and promote the cell differentiation. However, no
in vivo experiment was reported in this study [174].
3.5.3. Other tissue repair
Recently, the fabrication of a nanoﬁbrillar patch by
using BC and its application as a wound-healing platform
for traumatic tympanic membrane (ear drum) perforation
was reported. The nanostructured surface, biocompatibil-
ity, transparency, and appropriate mechanical propertieswere expected to meet the requirements of an ideal
wound-healing platform for tympanic membrane perfora-
tion. The tympanic membrane cells were found to well
adhere and proliferate on the BC nanoﬁbrillar patch, and
in vitro the growth and migration of cells were promoted
under the guidance of BC patch. Speciﬁc effects of BC patch
materials on the regeneration and healing of tympanic
membrane tissues were investigated through in vivo ani-
mal study (12 weeks Sprague-Dawley rats). It was reported
that the presence of BC patch materials signiﬁcantly
increased the tympanic membrane healing rate as well as
recovered the function of tympanic membrane better than
spontaneous healing [175].
BC was reported to be developed as biomaterial for the
reconstruction of damaged peripheral nerves via cellulosic
guidance channels. In vivo experiments were conducted on
the femoral nerve of Wistar rats for three months. Results
evaluation from histological analysis and postoperative
observation of motor recovery showed that BC neurotubes
can effectively prevent the formation of neuromas, while
allowing the accumulation of neurotrophic factors inside,
and facilitating the process of nerve regeneration [176].
3.6. Antimicrobial nanomaterials
Wound infection caused by high bacterial levels, espe-
cially the burn wounds, traumatic injuries, and surgical
procedures, is a signiﬁcant reason for delayed or prolonged
wound healing. Adherence and survival of pathogenic bac-
teria on the surface of wounds leading to concomitant
transmission to new hosts signiﬁcantly contribute to the
proliferation of pathogens, which considerably increases
the threat to human health. With increasing awareness of
infectious diseases and antibiotic resistance, many studies
were dedicated to the development of effective surface dis-
infection and alternative materials bearing antimicrobial
and other bioactive characteristics, viz. antimicrobial
wound dressing. Nanocellulose can provide a porous net-
work structure in the architecture of biomaterials, which
is beneﬁcial for potential transfer of antibiotics or other
medicines into the wound, meanwhile serving as an efﬁ-
cient physical barrier against any external infection
[177]. It is also reported that antimicrobial nanomaterials
from nanocellulose (carbohydrate nature) commonly
exhibited compatibility with biological tissue as well as
signiﬁcant bioavailability and biodegradability [178,179].
However, because of the fact that nanocellulose itself has
no antimicrobial activity and cannot prevent wound infec-
tion, nanocellulose-based antimicrobial biomaterials are
generally achieved by the conjunction of antimicrobial
agents and nanocellulose using physical or chemical
approaches. According to different types of antimicrobial
agents, nanocellulose-based antimicrobial biomaterials
can be divided in two parts, including nanomaterials incor-
porated with inorganic antimicrobial agents (mainly
involving silver particles (Ag) and its derivatives), and
organic antimicrobial agents (e.g. lysozyme).
It is reported that among the different antimicrobial
agents, silver has been most extensively studied and used
since ancient times to ﬁght infections and prevent spoil-
age. The silver nanoparticles with effective antibacterial,
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ing antibacterial agent [180]. Chemical reduction (AgNO3/
reducing agent) and simple impregnation are common
approach to introduce a silver antimicrobial agent into
nanocellulose-based materials. The antimicrobial efﬁcacy
of Ag nanoparticle in nanocellulose-based biomaterials
depends on the size and shape of synthesized nanoparti-
cles. It was reported that CNC nanohybrid materials con-
taining dendritic nanostructured Ag showed better
antibacterial activity than that of sphere nanostructured
Ag [181]. Recent studies attempted to incorporate both
Ag nanoparticles and CNC in polymeric matrices to offer
the synergy effects of antibacterial and mechanical rein-
forcement, such as poly(lactic acid)/CNC/Ag [182,183],
and poly(3-hydroxybutyrate-co-3-hydroxyvalerate)/CNC/
Ag materials [184] and waterborne polyurethane/CNC/Ag
[185]. Regarding the antibacterial nanomaterials from
CNF and Ag nanoparticles, it was reported that composites
composed of CNF and Ag nanoparticles can be fabricated
by an electrostatic assembly approach via polyelectrolytes
as macromolecular linkers between CNF and Ag nanoparti-
cles [186]. Fluorescent silver nanoclusters were dipped
into CNF materials with the mediation by poly(methacrylic
acid). The presence of ﬂuorescent silver nanoclusters pro-
vided both ﬂuorescence and antibacterial activities for
the composites [187]. The studies of Ag nanoparticle or
its derivatives (AgCl, silver sulfadiazine) introduced in BC
to develop BC/Ag antibacterial nanomaterials were most
intensively studied, which exhibited a high antimicrobial
activity [188–193,179] and good biocompatibility. Besides
Ag nanoparticles, recent studies reported that zinc-oxide
nanoparticles (ZnO) on CNC [194], CNF [195] or BC [196]
materials also showed some antibacterial effects.
With the aim of avoiding toxicity and unsustainable
effect of inorganic Ag nanoparticles, some novel organic
antibacterial agents, were incorporated in nanocellulose
to develop novel antibacterial materials. The reported
organic antibacterial agents used in nanocellulose-based
materials include CNC: porphyrin; CNF: octadecyldimethyl
(3-trimethoxysilylpropyl) ammonium chloride [197], alli-
cin and lysozyme [198], chitosan–benzalkonium chloride,
chitosan–methylisothiazolinone; and BC: gentamicin, e-
polylysine [199], benzalkonium chloride [200], sorbic acid
[201,202]. CNC was reported to be covalently grafted on
cationic porphyrin groups, which showed excellent efﬁ-
ciency of photodynamic inactivation towards bacteria. This
strategy was expected as the development of potential
photobactericidal nanomaterials [203,204]. Liu et al.
reported the preparation of sodium alginate/CNF antibac-
terial composites with the addition of chitosan–benzalko-
nium chloride or chitosan–methylisothiazolinone as
antibacterial agents. Both antibacterial agents were nano-
spherical shape (30 nm and 10 nm) and adsorbed on the
surface of CNF during several min, under the driving forces
of hydrogen bonds and electrostatic interactions. Further-
more, these composites were reported to display promis-
ing mechanical strength and excellent antibacterial
activity against Staphylococcus aureus [205,206]. In order
to enhance the antibacterial activity of BC, gentamicin-
activated BC membranes were prepared by chemically
grafting RGDC peptides (R: arginine; G: glycine; D: asparticacid; C: cysteine) with the crosslinking followed by cova-
lent attachment of gentamicin onto the surface of the BC
membrane network. It was reported that these gentami-
cin–RGDC-grafted BC membranes were bactericidal
against Streptococcus mutans but nontoxic to human der-
mal ﬁbroblasts, which showed potential application in
wound healing or drug delivery systems [207].
Recently, some researchers studied the antibacterial
property of nanocellulose with surface derivatization,
which means the development of nanocellulose antibacte-
rial materials without the use of antibacterial agents. Via a
nucleophilic displacement reaction starting from cellu-
lose-p-toluenesulfonic acid ester, the surface of CNF can
be amino-functionalized. Interestingly, it was reported that
electrospun PVA nanoﬁbers containing this amino-modi-
ﬁed CNF (with 6-deoxy-6-trisaminoethyl-amino agent at a
degree of substitution of 0.67) exhibited a high antimicro-
bial activity against S. aureus and Klebsiella pneumonia
[208]. However, it was a pity that the antimicrobial mecha-
nism from this amino-modiﬁed CNF was not investigated.
Similar studywas also reported on chemical grafting of ami-
noalkyl groups onto the surface of BC nanoﬁbrillar network
to provide its antimicrobial activity. In this study, the chem-
ical structure of amino-modiﬁed cellulose was compared
similarly with chitosan, which was regarded as the origin
and mimicking of antimicrobial property for modiﬁed BC
[209]. Butchosa et al. reported the use of partially deacety-
lated chitin nanocrystals in BC materials to develop all-
polysaccharide antimicrobial composites. It was reported
that this ‘‘green’’ composite with all natural components
showed strong antibacterial activitywith 99 ± 1% inhibition
of bacterial growth [210]. Recently, Ul-Islam et al. reported
that BC composites incorporated into small concentrations
of Cu-montmorillonite exhibited some antimicrobial activ-
ity, but without any mechanism investigation [211].
Most reported materials with nanocellulose with or
without antimicrobial agents in the forms of suspension,
composite, porous membrane/ﬁlm, and electrospun nano-
ﬁber, all present promising antimicrobial effects against,
e.g. Gram-positive bacterium (S. aureus), and Gram-
negative bacterium (Escherichia coli). However, many
interesting properties and pivotal issues on nanocellu-
lose-based antimicrobial biomaterials are still unknown,
especially regarding the reasonable balance between the
improvement of antimicrobial activity, duration of antimi-
crobial effect, and control of normal human cell damage.
3.7. Other biomedical applications
Besides the traditional biomedical applications dis-
cussed before, nanocellulose has been attempted to be used
in some new ﬁelds with special functions. A highly porous
CNF/polypyrrole composite was developed as an electro-
chemically controlled solid phase extraction biomaterial
for the capture of DNA oligomers. This biocomposite pos-
sessed a total anion exchange capacity of about 1.1 mol/
kg, and was reported to extract and release the negatively
charged ﬂuorophore-tagged DNA oligomers through the
galvanostatic oxidation and reduction of conformal poly-
pyrrole layer (30–50 nm) on CNF substrate. Resulting from
the high surface area of porous structure, the ion exchange
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magnitude higher than traditional ion exchange material,
and showed faster and better control of the polypyrrole
charge for the capture of DNA oligomers [212]. In another
study, this CNF/polypyrrole composite prepared with the
same strategy and source of CNF,was applied as the hemod-
ialysis membrane to purify blood. It was reported that this
biomaterial exhibited an effective removal of small uremic
toxins in blood and an improvement in thrombogenic prop-
erties with the coating of heparin, which were attributed to
superior ion exchange capability and large surface area of
themembrane. It should be also noted that due to the intro-
duction of natural CNF, the hemocompatibility of this com-
posite biomaterial was much better than commercial
synthetic membranes (such as polysulfone) [34,213].
Tabuchi et al. reported the ability of BC medium to
separate DNA fragments due to a double-mesh concept
combined with a stereo effect from BC-intrinsic three-
dimensional micrometer- to a nanometer-network
structure. It was shown that a solution of 0.49% hydroxy-
propylmethyl cellulose polymer containing 0.3% BC frag-
ments allowed excellent separation for a wide range ofFig. 5. Chemical structure of some ﬂuoresceDNA sizes (10 bp–15 kbp) as well as a high resolution of
single-nucleotide polymorphisms even though the viscos-
ity of BC medium was less than 5 cP [214].
BC was also reported as an innovative material for den-
tal root canal treatment. In comparison with conventional
paper point materials, BC showed greater compatibility
and biological characteristics for dental root canal treat-
ment. The absorption rate of BC-based biomaterials was
about 10-fold greater than that of paper point materials,
and BC-based biomaterials can preserve better tensile
strength under wet condition meeting the requirement of
high-expansion of dental root canal biomaterials. In addi-
tion, it was reported that when used for dental root canal
treatment in animal experiments, BC-based biomaterials
showed maintenance of physical integrity, and only a small
foreign body reaction [215].
4. Functional modiﬁcation of nanocellulose for
potential biomedical application
Diverse biomedical applications of nanocellulose
discussed in Section 3 are exciting, but modiﬁcation ofnt labeling molecules grafted on CNC.
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als is also important, which will determine its potential
biological applications.
By the means of introducing ﬂuorescent molecules on
the surface, nanocellulose can be converted to functional
nanoparticles with ﬂuorescent labeling ability. It is
expected that ﬂuorescent modiﬁcation on nanocellulose
enables the potential use in biomedical ﬁelds, such as opti-
cal bioimaging, biosensor, and photodynamic therapy. On
the other hand, characterized by various ﬂuorescence tech-
niques, ﬂuorescent labeled nanocellulose is easier to be
traced and evaluated for toxicity and bioactivity in materi-
als. Since the ﬁrst report of ﬂuorescent labeling on CNC
with ﬂuorescein-50-isothiocyanate (FITC) molecule [216],
more and more studies focus on this topic. To date, diverse
ﬂuorescent molecules have been attempted to covalently
attach on the surface of CNC, including FITC, Rhodamine
B isothiocyanate [62], pyrene dyes [217], terpyridine and
its derivatives [218], 1-pyrenebu-tyric acid N-hydroxy suc-
cinimide ester [219], 5-(and-6)-carboxyﬂuorescein succin-
imidyl ester, 5-(and-6)-carboxytetramethylrhod-amine
succinimidyl ester, Oregon Green 488 carboxylic acid,
succinimidyl ester [220], PEI-chlorin p6 derivatives [221],
5-(4, 6-dichlorotriazinyl) aminoﬂuorescein [222], and 7-
amino-4-methylcoumarin [223]. Fig. 5 shows the chemical
structure of some ﬂuorescent molecules that have been
grafted on CNC. It is sure that there is still a long way for
practical application of ﬂuorescent CNC in biology, but it
is also undoubted that the ﬂuorescently modiﬁed CNC is
so attracting that the breakthrough in this topic may bring
the revolution of biomedical materials.
Surface grafting of amino acid molecules can offer bio-
logically active building blocks on nanocellulose, which
may contribute to the potential of nanocellulose to be used
as a nanocarrier for DNA delivery. Chemical conjunction
between amino acid and CNC or CNF can be achieved with
two strategies: (1) esteriﬁcation reaction between Fmoc-
amino acid and CNC, and removal of Fmoc-protecting group
[224]; (2) activation of oxidized CNF to form a stable active
ester, and grafting of amino acid with the formation of
novel amide bond [225]. Recently, using the molecular rec-
ognition ability of DNA oligomeric base pairs, duplexing
complementary DNA oligonucleotides have been grafted
onto CNC to produce DNA-based biocompatible nanomate-
rials, which may be used as special biomaterials
for enzyme/protein immobilization [226]. Ferrocene-
decorated CNC can be prepared by grafting ethynylferro-
cene onto azide functionalized CNC using azide–alkyne
cycloaddition reaction, which can be assembled in
three-dimensional structures for potential application in
biosensors and bioelectrochemical assemblies [227].5. Conclusions and remarks
The aim of this article is to demonstrate the current
state of research and future development of nanocellulose
in the application of biomedicine through the discussion of
selected examples. Undoubtedly, nanocellulose has great
potential for the breakthrough of a novel generation of bio-
medical materials. Reported studies on nanocellulose haveled to signiﬁcant advancement with the promise of even
greater advances likely to come in the future. Overall,
creating controlled properties, reliable and reproducible
production techniques for biocompatible nanocellulose
(not only for BC) will be essential and beneﬁcial to pave
the way for greater acceptance of nanocellulose as a com-
mercially available material in biomedical applications.
Further comparison and investigation on different effects
of the three types of nanocellulose (CNC, CNF and BC) will
determine their respective applications in biomedical
materials.
Speciﬁcally, regarding cellular bioscaffold, the mecha-
nisms for cells and nanocellulose interaction remain enig-
matical and require intensive in vivo study. Furthermore,
on the basis of mechanism analysis, it is possible for future
study to regulate the interactions between cells and nano-
cellulose through controlling the macro- and microstruc-
ture of nanocellulose. Different pharmaceutical
molecules, together with growth factors, or antigenic
factors will be combinatorially organized in nanocellu-
lose-based drug carriers, and used for synergically medical
therapy purposes. The studies on the development of tis-
sue substitutes and repair biomaterials have made positive
progress (especially with BC), which promotes the launch
of several commercial products and practical usage in
clinic. On the one hand, novel nanocellulose-based tissue
substitutes and repair biomaterials will be more versatile
with the possible incorporation of biocompatible factors
or functional factors (such as anticoagulant factors). On
the other hand, covalent attachment of biologically active
ligand molecules to the nanocellulose framework can
enhance and alter its characteristics for speciﬁc applica-
tions, which may improve interactions between materials
and human tissues.
From both scientiﬁc and economic viewpoints, nanocel-
lulose, the resource and gift provided by Nature, is on the
threshold of a breakthrough driven by recent extraordinary
activities in the ﬁeld of biomedical applications.Acknowledgement
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